ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael R. Johnston
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnston, M. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Johnston, M. R.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1997;63:799
© 1997 The Society of Thoracic Surgeons

Invited Commentary

Michael R. Johnston, MD

Division of Thoracic Surgery Mount Sinai Hospital University of Toronto 600 University Ave, Rm 1525 Toronto, ON M5G 1X5 Canada

The first 20% of the full text of this article appears below.

See also page 796.

Isolated lung perfusion as a method of administering anticancer therapy is slowly evolving since my colleagues and I brought it into the modern era of thoracic surgery more than 10 years ago. Lung perfusion neatly weds the technology of cardiopulmonary bypass and the . . . [Full Text of this Article]


Related Article

Sequential Bilateral Isolated Lung Perfusion in the Rat: An Experimental Model
Sumihiko Nawata, Amir Abolhoda, Howard M. Ross, Ari Brooks, and Michael E. Burt
Ann. Thorac. Surg. 1997 63: 796-799. [Abstract] [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.